68 results
8-K
NBSE
NeuBase Therapeutics Inc
29 Sep 23
Submission of Matters to a Vote of Security Holders
4:10pm
and narrative discussion within the section of the Proxy Statement entitled “Executive Compensation.”
For
Against
Abstentions
Broker Non-Votes
DEFA14A
NBSE
NeuBase Therapeutics Inc
11 Aug 23
Additional proxy soliciting materials
6:18am
accounting firm for the fiscal year ending December 31, 2023; 3. To conduct an advisory (non-binding) vote on executive compensation; and 4. To approve
424B5
NBSE
NeuBase Therapeutics Inc
30 Jun 23
Prospectus supplement for primary offering
8:42am
companies. These provisions include, among other things, scaled disclosure requirements, including about our executive compensation arrangements.
We intend
424B5
ydlkdflp
29 Dec 22
Prospectus supplement for primary offering
5:03pm
8-K
6shq843d
12 Sep 22
Submission of Matters to a Vote of Security Holders
4:47pm
424B5
b03srj
27 Aug 21
Prospectus supplement for primary offering
5:21pm
8-K
stcciq
19 Aug 21
Submission of Matters to a Vote of Security Holders
8:00am
DEFA14A
igo9hi84x0i0me42
2 Jul 21
Additional proxy soliciting materials
7:06am
424B5
ja1af purppz
23 Apr 21
Prospectus supplement for primary offering
4:05pm
424B5
vtjd2o vwra4hwesd2f0
21 Apr 21
Prospectus supplement for primary offering
4:03pm